Genetic alteration in melanoma development

Balch, C.M., Buzaid, A.C., Soong, S.J., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton, A., Jr., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson. J.F. (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol., 19(16), 3635-3648.10.1200/JCO.2001.19.16.3635Search in Google Scholar

Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., Sondak, V. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406(6795), 536-540.Search in Google Scholar

Blackwood, M. A., Holmes, R., Synnestvedt, M., Young, M., George, C., Yang, H., Elder D. E., Schuchter, L. M., Guerry, D., Ganguly, A. (2002). Multiple primary melanoma revisited. Cancer., 94(8), 2248-2255.10.1002/cncr.10454Search in Google Scholar

Byrd, K.M., Wilson, D.C., Hoyler, S.S., Peck, G.L. (2004). Advanced presentation of melanoma in African Americans. J. Amer. Acad. Dermatol., 50(1), 142-143.10.1016/S0190-9622(03)02091-7Search in Google Scholar

Clark, W.H. Jr., Elder, D.E., Guerry, D. 4^th, Epstein, M.N., Greene, M.H., Van Horn, M. (1984). A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 15(12), 1147-1165.10.1016/S0046-8177(84)80310-XSearch in Google Scholar

Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H.N., Busam, K.J., Kutzner, H., Cho, K.H., Aiba, S., Brocker, E.B., LeBoit, P.E., Pinkel, D., Bastian, B.C. (2005). Distinct sets of genetic alterations in melanoma. New Engl. J. Med., 353(20), 2135-2147.10.1056/NEJMoa05009216291983Search in Google Scholar

Danen, E.H., Ten Berge, P.J., Van Muijen, G.N., Van't Hof-Grootenboer, A.E., Brocker, E.B., Ruiter, D.J. (1994). Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology, 24(3), 249-256.10.1111/j.1365-2559.1994.tb00517.x7515372Search in Google Scholar

Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G.D., Perrone, F., Luoni, C., Suardi, S., Frattini, M., Pilotti, S., Anichini, A., Tragni, G., Parmiani, G., Pierotti, M.A., Rodolfo, M. (2004). BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene, 23(35), 5968-5977.10.1038/sj.onc.120778015195137Search in Google Scholar

Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R., Futreal, P.A. (2002). Mutations of the BRAF gene in human cancer. Nature, 417(6892), 949-954.Search in Google Scholar

de Snoo, F.A., Hayward, N.K. (2005). Cutaneous melanoma susceptibility and progression genes. Cancer Lett., 230(2), 153-186.10.1016/j.canlet.2004.12.03316297704Search in Google Scholar

Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C., van den Oord, J.J. (2001). Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J. Invest. Dermatol., 117(6), 1483-1489.10.1046/j.0022-202x.2001.01601.x11886512Search in Google Scholar

Dhawan, P., Singh, A.B., Ellis, D.L., Richmond, A. (2002). Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res., 62(24), 7335-7342.Search in Google Scholar

Diepgen, T.L., Mahler, V. (2002). The epidemiology of skin cancer. Brit. J. Dermatol., 146 (Suppl. 61), 1-6.10.1046/j.1365-2133.146.s61.2.x11966724Search in Google Scholar

Du, J., Miller, A.J., Widlund, H.R., Horstmann, M.A., Ramaswamy, S., Fisher, D.E. (2003). MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Amer. J. Pathol., 163(1), 333-343.10.1016/S0002-9440(10)63657-7Search in Google Scholar

Duncan, L.M., Deeds, J., Cronin, F.E., Donovan, M., Sober, A.J., Kauffman, M., McCarthy, J.J. (2001). Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol., 19(2), 568-576.10.1200/JCO.2001.19.2.568Search in Google Scholar

Edwards, R.H., Ward, M.R., Wu, H., Medina, C.A., Brose, M.S., Volpe, P., Nussen-Lee, S., Haupt, H.M., Martin, A.M., Herlyn, M., Lessin, S.R., Weber, B.L. (2004). Absence of BRAF mutations in UV-protected mucosal melanomas. J. Med. Genet., 41(4), 270-272.10.1136/jmg.2003.016667Search in Google Scholar

Felding-Habermann, B., Fransvea, E., O'Toole, T.E., Manzuk, L., Faha, B., Hensler, M. (2002). Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis, 19(5), 427-436.10.1023/A:1016377114119Search in Google Scholar

Garbe, C., McLeod, G.R., Buettner, P.G. (2000). Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer, 89, 1269-1278.10.1002/1097-0142(20000915)89:6<1269::AID-CNCR11>3.0.CO;2-CSearch in Google Scholar

Garraway, L.A., Widlund, H.R., Rubin, M.A., Getz, G., Berger, A.J., Ramaswamy, S., Beroukhim, R., Milner, D.A., Granter, S.R., Du, J., Lee, C., Wagner, S.N., Li, C., Golub, T.R., Rimm, D.L., Meyerson, M.L., Fisher, D.E., Sellers, W.R. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature, 436(7047), 117-122.Search in Google Scholar

Goldstein, A.M., Chan, M., Harland, M., Hayward, N.K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Cannon Albright, L.A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D.E., Ghiorzo, P., Gillanders, E.M., Gruis, N.A., Hansson, J., Hogg, D., Holland, E.A., Kanetsky, P.A., Kefford, R.F., Teresa Landi, M., Lang, J., Leachman, S.A., Mackie, R.M., Magnusson, V., Mann, G.J., Newton Bishop, J., Palmer, J.M., Puig, S., Puig-Butille, J.A., Stark, M., Tsao, H., Tucker, M.A., Whitaker, L., Yakobson, E. (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet., 44(2), 99-106.10.1136/jmg.2006.043802Search in Google Scholar

Gorden, A., Osman, I., Gai, W., He, D., Huang, W., Davidson, A., Houghton, A.N., Busam, K., Polsky, D. (2003). Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res., 63(14), 3955-3957.Search in Google Scholar

Gray-Schopfer, V.C., Cheong, S.C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z.A., Marais, R., Wynford-Thomas, D., Bennett, D.C. (2006). Cellular senescence in naevi and immortalisation in melanoma: A role for p16? Br. J. Cancer, 95(4), 496-505.10.1038/sj.bjc.6603283Search in Google Scholar

Hammock, L., Cohen, C., Carlson, G., Murray, D., Ross, J.S., Sheehan, C., Nazir, T.M., Carlson, J.A. (2006). Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma. J. Cutan. Pathol., 33(9), 599-607.10.1111/j.1600-0560.2006.00501.xSearch in Google Scholar

Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B.L., Federman, S., Miller, J.R. 3^rd, Allen, R.E., Singer, M.I., Leong, S.P., Ljung, B.M., Sagebiel, R.W., Kashani-Sabet, M. (2005). The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA, 102(17), 6092-6097.10.1073/pnas.0501564102Search in Google Scholar

Hofmann, U.B., Westphal, J.R., Waas, E.T., Becker, J.C., Ruiter, D.J., van Muijen, G.N. (2000) Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J. Invest. Dermatol., 115(4), 625-632.10.1046/j.1523-1747.2000.00114.xSearch in Google Scholar

Hornberg, J.J., Bruggeman, F.J., Westerhoff, H.V., Lankelma, J. (2006). Cancer: A Systems Biology disease. Biosystems, 83(2-3), 81-90.10.1016/j.biosystems.2005.05.014Search in Google Scholar

Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., Herlyn, M. (2000a). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Amer. J. Pathol., 156(5), 1515-1525.10.1016/S0002-9440(10)65023-7Search in Google Scholar

Hsu, M., Andl, T., Li, G., Meinkoth, J.L., Herlyn, M. (2000b). Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci., 113 (Pt 9), 1535-1542.10.1242/jcs.113.9.1535Search in Google Scholar

Jiveskog, S., Ragnarsson-Olding, B., Platz, A., Ringborg, U. (1998). N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J. Invest. Dermatol., 111(5), 757-761.10.1046/j.1523-1747.1998.00376.xSearch in Google Scholar

Kumar, R., Angelini, S., Snellman, E., Hemminki, K. (2004). BRAF mutations are common somatic events in melanocytic nevi. J. Invest. Dermatol., 122(2), 342-348.10.1046/j.0022-202X.2004.22225.xSearch in Google Scholar

Li, X., Regezi, J., Ross, F.P., Blystone, S., Ilic, D., Leong, S.P., Ramos, D.M. (2001). Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro. J. Cell Sci., 114(Pt 14), 2665-2672.10.1242/jcs.114.14.2665Search in Google Scholar

Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., Parsons, R. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16(1), 64-67.10.1038/ng0597-64Search in Google Scholar

Miller, A.J., Mihm, M.C. Jr. (2006). Melanoma. New Engl. J. Med., 355(1), 51-65.10.1056/NEJMra052166Search in Google Scholar

Ortega, S., Malumbres, M., Barbacid, M. (2002). Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta, 1602(1), 73-87.10.1016/S0304-419X(02)00037-9Search in Google Scholar

Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D.G., Schiffmann, D. (1999). Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet., 36(8), 610-614.Search in Google Scholar

Petitelerc, E., Stromblad, S., von Schalscha, T.L., Mitjans, F., Piulats, J., Montgomery, A.M., Cheresh, D.A., Brooks, P.C. (1999). Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res., 59(11), 2724-2730.Search in Google Scholar

Pollock, P.M., Harper, U.L., Hansen, K.S., Yudt, L.M., Stark, M., Robbins, C.M., Moses, T.Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N.K., Trent, J.M., Meltzer, P.S. (2003). High frequency of BRAF mutations in nevi. Nat. Genet., 33(1), 19-20.10.1038/ng105412447372Search in Google Scholar

Poynter, J.N., Elder, J.T., Fullen, D.R., Nair, R.P., Soengas, M.S., Johnson, T.M., Redman, B., Thomas, N.E., Gruber, S.B. (2006). BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res., 16(4), 267-273.10.1097/01.cmr.0000222600.73179.f316845322Search in Google Scholar

Reifenberger, J., Knobbe, C.B., Sterzinger, A.A., Blaschke, B., Schulte, K.W., Ruzicka, T., Reifenberger, G. (2004). Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int. J. Cancer, 109(3), 377-384.10.1002/ijc.1172214961576Search in Google Scholar

Rhodes, A.R., Weinstock, M.A., Fitzpatrick, T.B., et al. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA, 258(21), 3146-3154.10.1001/jama.1987.03400210088032Search in Google Scholar

Rodolfo, M., Daniotti, M., Vallacchi, V. (2004). Genetic progression of metastatic melanoma. Cancer Lett., 214(2), 133-147.10.1016/j.canlet.2004.06.04915363539Search in Google Scholar

Rusciano, D. (2000). Differentiation and metastasis in melanoma. Crit. Rev. Oncog., 11(2), 147-163.Search in Google Scholar

Saldanha, G., Purnell, D., Fletcher, A., Potter, L., Gillies, A., Pringle, J.H. (2004). High BRAF mutation frequency does not characterize all melanocytic tumor types. Int. J. Cancer, 111(5), 705-710.10.1002/ijc.2032515252839Search in Google Scholar

Sasaki, Y., Niu, C., Makino, R., Kudo, C., Sun, C., Watanabe, H., Matsunaga, J., Takahashi, K., Tagami, H., Aiba, S., Horii, A. (2004). BRAF point mutations in primary melanoma show different prevalences by subtype. J. Invest. Dermatol., 123(1), 177-183.10.1111/j.0022-202X.2004.22722.x15191558Search in Google Scholar

Sharpless, N.E., DePinho, R.A. (2005). Cancer: Crime and punishment. Nature, 436(7051), 636-637.Search in Google Scholar

Stahl, J.M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J.Q., Bosenberg, M.W., Kester, M., Sandirasegarane, L., Robertson, G.P. (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res., 64(19), 7002-7010.10.1158/0008-5472.CAN-04-139915466193Search in Google Scholar

Takeuchi, H., Kuo, C., Morton, D.L., Wang, H.J., Hoon, D.S. (2003). Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. Cancer Res., 63(2), 441-448.Search in Google Scholar

Thomas, N.E., Alexander, A., Edmiston, S.N., Parrish, E., Millikan, R.C., Berwick, M., Groben, P., Ollila, D.W., Mattingly, D., Conway, K. (2004). Tandem BRAF mutations in primary invasive melanomas. J. Invest. Dermatol., 122(5), 1245-1250.10.1111/j.0022-202X.2004.22523.x15140228Search in Google Scholar

Tsao, H., Goel, V., Wu, H., Yang, G., Haluska, F.G. (2004). Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol., 122(2), 337-341.10.1046/j.0022-202X.2004.22243.x258666815009714Search in Google Scholar

Tsao, H., Zhang, X., Fowlkes, K., Haluska, F.G. (2000). Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res., 60(7), 1800-1804.Search in Google Scholar

Uribe, P., Wistuba, I.I., Gonzalez, S. (2003). BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Amer. J. Dermatopathol., 25(5), 365-670.10.1097/00000372-200310000-0000114501284Search in Google Scholar

van Elsas, A., Zerp, S.F., van der Flier, S., Kruse, K.M., Aarnoudse, C., Hayward, N.K., Ruiter, D.J., Schrier, P.I. (1996). Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Amer. J. Pathol., 149(3), 883-893.Search in Google Scholar

Williams, M.L., Sagebiel, R.W. (1994). Melanoma risk factors and atypical moles. West. J. Med., 160(4), 343-350.Search in Google Scholar

Wu, H., Goel, V., Haluska, F.G. (2003). PTEN signaling pathways in melanoma. Oncogene, 22(20), 3113-3122.10.1038/sj.onc.1206451Search in Google Scholar

Yazdi, A.S., Palmedo, G., Flaig, M.J., Puchta, U., Reckwerth, A., Rutten, A., Mentzel, T., Hugel, H., Hantschke, M., Schmid-Wendtner, M.H., Kutzner, H., Sander, C.A. (2003). Mutations of the BRAF gene in benign and malignant melanocytic lesions. J. Invest. Dermatol., 121(5), 1160-1162.10.1046/j.1523-1747.2003.12559.xSearch in Google Scholar

Zhang, Y., Xiong, Y., Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92(6), 725-734.10.1016/S0092-8674(00)81401-4Search in Google Scholar